BI 2536
BI 2536 Uses, Dosage, Side Effects, Food Interaction and all others data.
BI 2536 is under investigation in clinical trial NCT00376623 (Efficacy and Safety of BI 2536 in Advanced or Metastatic Non Small Cell Lung Cancer).
| Trade Name | BI 2536 |
| Generic | BI 2536 |
| Type | |
| Formula | C28H39N7O3 |
| Weight | Average: 521.666 Monoisotopic: 521.311438144 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here BI 2536
